Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

References

• United Nations.World Population Ageing 2019. Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf. 1220, 2020.
   Google Scholar
• Long SB, Blaha MJ, Blumenthal RS, Michos ED. Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clin Interv Aging. 2011;6:27–35.21472089
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Mussi C, Pellegrini E, et al. Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. Clin Interv Aging. 2014;9:425–432.24669190
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.31504418
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1997–2007.27838723
   PubMed Web of Science ®Google Scholar
• Singh S, Zieman S, Go AS, et al. Statins for primary prevention in older adults-moving toward evidence-based decision-making. J Am Geriatr Soc. 2018;66(11):2188–2196.30277567
   PubMed Web of Science ®Google Scholar
• Verdoia M, Galasso G, Filardi PP, De Luca G. Statins and elderly: from clinical trials to daily practice. Curr Vasc Pharmacol. 2019;17(3):233–238.29956633
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285–e350.30423393
   PubMed Web of Science ®Google Scholar
• Gazzola K, Vigna GB. Hypolipidemic drugs in elderly subjects: indications and limits. Nutri Metabol e Cardiovasc Dis. 2016;26:1064–1070.
   Web of Science ®Google Scholar
• Miller MD, Towers A. Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Pittsburg: University of Pittsburgh; 1991:596.
   Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65.
   PubMedGoogle Scholar
• Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734–739.6846631
   PubMed Web of Science ®Google Scholar
• Ardoino I, Franchi C, Nobili A, et al. Pain and frailty in hospitalized older adults. Pain Ther. 2020;9:727–740.33058084
   PubMed Web of Science ®Google Scholar
• Franchi C, Mannucci P, Nobili A, Ardoino I, REPOSI investigators. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people. Eur J Clin Pharmacol. 2020;76:459–465.31853593
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline for Good Clinical Practice E6(R2). London: European Medicines Agency; 2016. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-6-r2-guideline-good-clinical-practice-step-5_en.pdf. Accessed 69, 2021.
   Google Scholar
• Marcucci M, Franchi C, Nobili A, et al. Defining aging phenotypes and related outcomes: clues to recognize frailty in hospitalized older patients. J Gerontol a Biol Sci Med Sci. 2017;72(3):395–402.28364542
   PubMed Web of Science ®Google Scholar
• Greenacre MJ. Correspondence Analysis in Practice. London, UK: Academic; 1993:32–37.
   Google Scholar
• Husson F, Le S, Pages J. Exploratory Multivariate Analysis by Example Using R. Boca Raton, FL: Chapman & Hall/CRC; 2011.
   Google Scholar
• Hennig C. Cluster wise assessment of cluster stability. Comput Stat Data Anal. 2007;52:258–271.
   Web of Science ®Google Scholar
• De La Higuera L, Riva E, Djade CD, et al. Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients. Intern Emerg Med. 2014;9:735–747.24338497
   PubMed Web of Science ®Google Scholar
• Damiani I, Corsini A, Bellosta S. Potential statin drug interactions in elderly patients: a review. Expert Opin Drug Metab Toxicol. 2020;16(12):1133–1145. doi:10.1080/17425255.2020.182232432909838
   PubMed Web of Science ®Google Scholar
• De Pádua Borges R, Degobi NAH, Bertoluci MC. Choosing statins: a review to guide clinical practice. Arch Endocrinol Metab. 2020;64(6):639–653. doi:10.20945/2359-3997000000306
   Web of Science ®Google Scholar
• Toth PP, Patti AM, Giglio RV, et al. Management of Statin Intolerance in 2018: still more questions than answers. Am J Cardiovasc Drugs. 2018;18(3):157–173. doi:10.1007/s40256-017-0259-729318532
   PubMed Web of Science ®Google Scholar
• Tibuakuu M, Blumenthal RS, Martin SS Bempedoic Acid for LDL-C Lowering: what Do We Know? Available from: https://www.acc.org/latest-in-cardiology/articles/2020/08/10/08/21/bempedoic-acid-for-ldl-c-lowering#:~:text=Bempedoic%20acid%20is%20a%20new,biosynthesis%20pathway%20in%20the%20liver.&text=Whereas%20statins%20inhibit%20HMG%20CoA,upstream%20of%20HMG%20CoA%20reductase.
   Google Scholar
• The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy 2019. Rome: Italian Medicines Agency, 2020.
   Google Scholar
• Viscogliosi G, Donfrancesco C, Lo Noce C, et al. Prevalence and correlates of statin underuse for secondary prevention of cardiovascular disease in older adults 65-79 years of age: the Italian health examination survey 2008-2012. Rejuvenation Res. 2020;23(5):394–400. doi:10.1089/rej.2019.226832008438
   PubMed Web of Science ®Google Scholar
• Arca M, Ansell D, Averna M, et al. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice. Atherosclerosis. 2018;271:120–127. doi:10.1016/j.atherosclerosis.2018.02.02429499359
   PubMed Web of Science ®Google Scholar
• Liguori I, Aran L, Bulli G, et al. Statins in cardiovascular prevention in the oldest-old. A black hole. J Gerontol Geriatrics. 2017;65:263–270.
   Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet. 2019;393:407–415.
   PubMed Web of Science ®Google Scholar
• Ruscica M, Macchi C, Pavanello C, Corsini A, Sahebkar A, Sirtori CR. Appropriateness of statin prescription in the elderly. Eur J Intern Med. 2018;50:33–40.29310996
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Lancellotti G, Mussi C. Management of high cholesterol levels in older people. Geriatr Gerontol Int. 2019;19(5):375–383.30900369
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;2014(63):2889–2934.
   Google Scholar
• Borne E, Meyer N, Rybarczyck-Vigouret MC, et al. Potential statin overuse in older patients: a retrospective cross‑sectional study using French health insurance databases. Drugs Aging. 2019;36:947–955.31317420
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Franchi C, Rocchi MBL, et al.; On behalf of REPOSI Investigators. Prevalence and determinants of the use of lipid-lowering agents in a population of older hospitalized patients: the findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study. Drugs Aging. 2017;34:311–319.28299634
   PubMed Web of Science ®Google Scholar